
Stop glamorizing the hustle and start glamorizing the mussel

Synthetic Biologist - Foundry Theorist - American Wetware - stay humble biodesigners

Stop glamorizing the hustle and start glamorizing the mussel

The future is wet cloud
wet lab is the new neocloud

We are growing at a breakneck clip and have ambitious engineering goals in therapeutics. Expanding our MTS team across chemistry, assay dev, translation and the clinic: - MTS, Chemistry - MTS, Medicinal Chemistry - MTS, Molecular Design - MTS, Experimental Biology + Assay Development - MTS, Translational Science - MTS, Clinical Development - MTS, Clinical Operations - MTS, Clinical Data + Statistical Programming - MTS, Biostatistics + Trial Design High-intensity, founder-type roles. Translate a deep understanding of a biological domain into a roadmap of benchmarks, then build and manage your own scientific team. Our MTS have built companies, run drug programs and scaled complex technical projects. In person in Mission Bay, San Francisco. We keep meetings to a minimum. Tight deadlines and customer commitments sometimes require late hours. 350K–500K+ OTE + equity. Visa sponsorship and relocation assistance. Our process is typically completed within two weeks. Frontier AI labs/pharma use our benchmarks to assess biological capabilities and safeguards. Our work appears in research announcements and model cards, including: - GDPx biology: gdpx.semianalysis.com/domain… - Fireworks SII: fireworks.ai/specialized-int… - Gemini 4 Hydrogen: blog.google/innovation-and-a… - Claude Fable 5.1/Mythos 5.1 system card: www-cdn.anthropic.com/0339e6… - Claude Opus 5.5 system card: www-cdn.anthropic.com/fc1b44… - Grok 4.7 model card: media.x.ai/v1/website/card4p… - xAI Biosecurity report: x.ai/news/biosafety-at-the-f… Apply at jobs.ashbyhq.com/latchbio. Or send an email to kenny[at]latch[dot]bio.

If biotech ever burns you out just remember that sometimes 70% ethanol can be more effective than 100% ethanol

Investing in Anthropic presents a strange paradox. If the ants are wrong about their commercial prospects, there's no reason to buy their shares. But if they're right about the transformative or potentially catastrophic implications of their technology, the world could change so radically that owning shares becomes meaningless. So the investment thesis requires threading a very narrow needle: believing Anthropic will be enormously successful economically, but that its leadership is fundamentally wrong about the consequences of that success. And even in that middle scenario, it's unclear how much upside remains for investors at today's valuation. Also, they are all vocal members of a crazy human extinction apocalpyse movement.

Excited today to announce the first two papers from @Kimia_Tx, expanding the scope of computational methods in drug discovery on fronts both experimental (dealing with methods generating 1000x more data) and computational (speeding up search 150x):

Career update/news including that I'm hiring! Late in the summer, I made the jump to @AnthropicAI to help co-lead a moonshot effort in genetic medicine. I'm hoping to have a proper update to share publicly fairly soon, but if you know my collection of interests (AI, clinical genetics, therapeutics, rare disease non-profits), you are unlikely to be surprised. Much of the upfront effort here requires infra for moving atoms as well as bits, and we explicitly want to lean deeply into collaborations with academics, non-profits, and key industry partners in the space. If either of the below roles sound like you, please apply through the link. More to come! Program Manager: job-boards.greenhouse.io/ant… CMC and Manufacturing Lead: job-boards.greenhouse.io/ant…

Who is innovating in the space of bioproducts for religious purposes? What is the TAM for sacred biology?

This was a really interesting moment. When a protocol doesn’t work, my mind tends to focus on the tangible inputs e.g. the water had the wrong minerals, the enzyme stocks were bad, the sample was degraded It makes sense that time is a key variable. But my brain, at least, isn’t primed to care about the difference between 60 and 90 seconds AI productivity gains in the lab might look like paying attention to the little things
What's the unobserved variable between magic hands and bad lab results? "Time. It's Always Time." ― Anna Marie Wagner of @transfyrai on the @iGEM stage (a few wild stories of time-based experimental variability in thread)

My dream job is Isaac from the Love Boat except instead of fixing your love life we sort out your biotech problems (I am also a bar tender and we fix your love life too)

Honestly super chill and great foresight from the #iGEM2026 organizers to schedule it so that everyone could get home in time to play GTA 6

If you’re at #igem2026 I’ll be interviewing Anna Marie Wagner, CEO of Transfyr on the main stage in 10 minutes!



everyone wants AI to cure cancer 57% of AI drugs in clinical trials are cancer drugs. 80% are small molecules more drugs that can stop a heart than ever. we're engineering that part out 🧵

How it feels to build an AI dashboard for a project you never start